Latest Breaking News On - Nct02426086 - Page 1 : comparemela.com

The first-in-class telomerase inhibitor imetelstat is poised to expand the myelofibrosis treatment armamentarium should it prove safe and effective in the newly initiated phase 3 IMpactMF trial.

New yorkUnited statesJohno mascarenhasIcahn school of medicine at mount sinaiBlood cancersMyeloid disordersIcahn schoolMount sinaiMyelofibrosis symptom assessment formPatients with myelofibrosisImpactmf trialIcahn school of medicine at mount sinaiImbark trial